Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: United Therapeutics Corporation, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
United Therapeutics Corporation June 26, 202590.2%
-
United Therapeutics Corporation June 26, 202491.7%
-
United Therapeutics Corporation June 26, 202392.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 21, 2025 | United Therapeutics Corporation | Option exercise | +3,000 | $175.43 | $526,290 |
| Apr 21, 2025 | United Therapeutics Corporation | Open-market sale | −3,000 | $285.57 | $856,710 |
| Apr 14, 2025 | United Therapeutics Corporation | Option exercise | +3,000 | $175.43 | $526,290 |
| Apr 14, 2025 | United Therapeutics Corporation | Open-market sale | −3,000 | $285.16 | $855,480 |
| Apr 7, 2025 | United Therapeutics Corporation | Option exercise | +4,000 | $175.43 | $701,720 |
| Apr 7, 2025 | United Therapeutics Corporation | Open-market sale | −4,000 | $284.55 | $1,138,200 |
| Aug 2, 2024 | United Therapeutics Corporation | Option exercise | +5,000 | $175.43 | $877,150 |
| Aug 2, 2024 | United Therapeutics Corporation | Open-market sale | −900 | $320.39 | $288,351 |
| Aug 2, 2024 | United Therapeutics Corporation | Open-market sale | −900 | $321.29 | $289,161 |
| Aug 2, 2024 | United Therapeutics Corporation | Open-market sale | −900 | $326.40 | $293,760 |
| Aug 2, 2024 | United Therapeutics Corporation | Open-market sale | −1,300 | $327.96 | $426,348 |
| Aug 2, 2024 | United Therapeutics Corporation | Open-market sale | −900 | $328.99 | $296,091 |
| Aug 2, 2024 | United Therapeutics Corporation | Open-market sale | −100 | $330.39 | $33,039 |
| Apr 22, 2024 | United Therapeutics Corporation | Option exercise | +3,000 | $88.03 | $264,090 |
| Apr 22, 2024 | United Therapeutics Corporation | Sold back to the company | −3,000 | $234.06 | $702,180 |
Questions about Raymond Dwek
What boards is Raymond Dwek on?
Raymond Dwek sits on the board of United Therapeutics Corporation.
How long has Raymond Dwek served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.